These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35953152)

  • 1. Roles of cytochrome P450 enzymes in pharmacology and toxicology: Past, present, and future.
    Guengerich FP
    Adv Pharmacol; 2022; 95():1-47. PubMed ID: 35953152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
    Guengerich FP
    AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytochrome P450 enzymes in drug-drug interactions.
    Guengerich FP
    Adv Pharmacol; 1997; 43():7-35. PubMed ID: 9342171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A history of the roles of cytochrome P450 enzymes in the toxicity of drugs.
    Guengerich FP
    Toxicol Res; 2021 Jan; 37(1):1-23. PubMed ID: 32837681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.
    Guengerich FP
    Pharmacol Rev; 2024 Oct; 76(6):1104-1132. PubMed ID: 39054072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
    Guengerich FP
    Chem Res Toxicol; 2017 Jan; 30(1):2-12. PubMed ID: 27472660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity.
    Guengerich FP
    Toxicol Lett; 1994 Feb; 70(2):133-8. PubMed ID: 8296317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development.
    Fukami T; Yokoi T; Nakajima M
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():405-425. PubMed ID: 34499522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Structural Insights into Cytochrome P450 Function.
    Guengerich FP; Waterman MR; Egli M
    Trends Pharmacol Sci; 2016 Aug; 37(8):625-640. PubMed ID: 27267697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects.
    Rendic SP
    Arch Toxicol; 2021 May; 95(5):1535-1546. PubMed ID: 33719007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen Surrogate Systems for Supporting Human Drug-Metabolizing Cytochrome P450 Enzymes.
    Strohmaier SJ; De Voss JJ; Jurva U; Andersson S; Gillam EMJ
    Drug Metab Dispos; 2020 Jun; 48(6):432-437. PubMed ID: 32238418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A passion for P450s (rememberances of the early history of research on cytochrome P450).
    Estabrook RW
    Drug Metab Dispos; 2003 Dec; 31(12):1461-73. PubMed ID: 14625342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo condition.
    Wienkers LC
    Eur J Pharm Sci; 2002 Apr; 15(3):239-42. PubMed ID: 11923055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications.
    Guengerich FP
    Biomol Ther (Seoul); 2022 Jan; 30(1):1-18. PubMed ID: 34475272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytochrome P450 enzymes expressed in bacteria: reagents to probe molecular interactions in toxicology.
    Gillam EM
    Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):877-86. PubMed ID: 9807658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition.
    Gonzalez E; Jain S; Shah P; Torimoto-Katori N; Zakharov A; Nguyễn ÐT; Sakamuru S; Huang R; Xia M; Obach RS; Hop CECA; Simeonov A; Xu X
    Drug Metab Dispos; 2021 Sep; 49(9):822-832. PubMed ID: 34183376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.